Gubra Sets 2030 Strategy to Expand Clinical Pipeline
Gubra outlined plans to scale its innovation engine and expand its clinical-stage pipeline, citing four clinical assets, two partnered Phase 2 obesity programs and its GUB-UCN2 platform.
Gubra outlined plans to scale its innovation engine and expand its clinical-stage pipeline, citing four clinical assets, two partnered Phase 2 obesity programs and its GUB-UCN2 platform.